Skip to main content
HHS
NASDAQ Trade & Services

Harte Hanks Reports Q1 2026 Revenue Decline and Increased Losses; Cash Balance Remains Strong

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
7
Price
$2.81
Mkt Cap
$20.836M
52W Low
$2.22
52W High
$5.39
Market data snapshot near publication time

summarizeSummary

Harte Hanks announced Q1 2026 financial results showing a 10.3% revenue decrease and worsening profitability, though the company highlighted its strong cash position and ongoing strategic alignment.


check_boxKey Events

  • Revenue Decline

    Total revenues for Q1 2026 were $37.3 million, a 10.3% decrease compared to $41.6 million in Q1 2025.

  • Increased Operating and Net Losses

    Operating loss widened to $768 thousand from $40 thousand in the prior year, and net loss increased to $0.6 million from $0.4 million.

  • EBITDA Significantly Lower

    EBITDA for Q1 2026 was $0.3 million, down from $1.0 million in Q1 2025. Adjusted EBITDA also fell to $0.7 million from $1.8 million.

  • Strong Balance Sheet Maintained

    The company ended the quarter with a cash balance of $4.5 million and no outstanding debt, providing financial stability despite operational challenges.


auto_awesomeAnalysis

Harte Hanks reported a significant 10.3% year-over-year revenue decline for Q1 2026, alongside increased operating and net losses, and a substantial drop in EBITDA. While these results indicate ongoing financial challenges, the company maintains a strong balance sheet with $4.5 million in cash and no outstanding debt, which provides a buffer as it pursues its growth strategy.

At the time of this filing, HHS was trading at $2.81 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $20.8M. The 52-week trading range was $2.22 to $5.39. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HHS - Latest Insights

HHS
May 14, 2026, 4:24 PM EDT
Filing Type: 8-K
Importance Score:
7
HHS
Mar 17, 2026, 5:20 PM EDT
Filing Type: 10-K
Importance Score:
7